BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 15161008)

  • 1. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.
    Okamura M; Kobayashi M; Suzuki F; Shimada J; Sakagami H
    Anticancer Res; 2007; 27(5A):3331-7. PubMed ID: 17970078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
    Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
    Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells.
    Azuma M; Harada K; Supriatno ; Tamatani T; Motegi K; Ashida Y; Sato M
    Int J Oncol; 2004 Jun; 24(6):1449-55. PubMed ID: 15138587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.
    Inoue K; Kulsum U; Chowdhury SA; Fujisawa S; Ishihara M; Yokoe I; Sakagami H
    Anticancer Res; 2005; 25(6B):4053-9. PubMed ID: 16309199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
    Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
    Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activity of styrylchromones against human tumor cell lines.
    Momoi K; Sugita Y; Ishihara M; Satoh K; Kikuchi H; Hashimoto K; Yokoe I; Nishikawa H; Fujisawa S; Sakagami H
    In Vivo; 2005; 19(1):157-63. PubMed ID: 15796168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines.
    Chu Q; Amano O; Kanda Y; Kunii S; Wang Q; Sakagami H
    Anticancer Res; 2009 Dec; 29(12):5023-31. PubMed ID: 20044612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
    Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
    Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
    Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line.
    Ohtani T; Hatori M; Ito H; Takizawa K; Kamijo R; Nagumo M
    Anticancer Res; 2000; 20(5A):3117-21. PubMed ID: 11062731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific cytotoxicity and type of cell death induced by peplomycin in oral squamous cell carcinoma cell lines.
    Liu Y; Sakagami H; Amano O; Kikuchi H; Nakamura Y; Ishihara M; Kanda Y; Kunii S; Zhang W; Yu G
    Anticancer Res; 2008; 28(4B):2197-204. PubMed ID: 18751395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
    Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
    Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
    Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
    Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.